Company Profile
Aurisco Pharmaceutical provides the research, development, production and sales of special complex APIs, pharmaceutical intermediates and preparations globally. The company offers APIs and intermediates of respiratory system, cardiovascular, anti-infection, nervous system, anti-tumor, and women's health drugs eplerenone, an API to treat cardiovascular diseases, lowering blood pressure, and treating heart failure.
Its portfolio also includes futicasone propionate, used for the treatment of asthma, respiratory tract diseases, and rhinitis, Tenofovir, an anti-infection used to treat AIDS and hepatitis B, pregabalin for the treatment of anti-epileptic, analgesic, and anti-anxiety purposes
For neuralgia, abiraterone acetate to treat prostate cancer, and dydrogesterone, to treat endogenous for women's heath. Aurisco Pharmaceutical Co.,Ltd. was founded in 1998 and is headquartered in Tiantai, China.